ProfileGDS4718 / 225196_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 80% 72% 79% 79% 72% 87% 82% 77% 70% 78% 79% 72% 82% 95% 87% 81% 80% 85% 90% 76% 80% 79% 79% 80% 78% 89% 78% 88% 74% 84% 75% 90% 68% 73% 79% 81% 77% 78% 79% 83% 79% 77% 86% 87% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.8335380
GSM549102patient 115, normal, homogenized [OPG study]7.0180372
GSM549104patient 119, normal, homogenized [OPG study]7.8104879
GSM549108patient 138, normal, homogenized [OPG study]7.6818879
GSM549119patient 077, normal, homogenized [OPG study]6.9834172
GSM549133patient 032, cancer, homogenized [OPG study]8.8245987
GSM549139patient 042, cancer, homogenized [OPG study]8.097982
GSM549099patient 107, normal, homogenized [OPG study]7.4128177
GSM549109patient 139, normal, homogenized [OPG study]6.8797770
GSM549110patient 046, normal, homogenized [OPG study]7.6164778
GSM549114patient 063, normal, homogenized [OPG study]7.8082179
GSM549122patient 082, normal, homogenized [OPG study]7.0290872
GSM549134patient 033, cancer, homogenized [OPG study]8.0953882
GSM549136patient 036, cancer, homogenized [OPG study]10.147595
GSM549140patient 044, cancer, homogenized [OPG study]8.7500587
GSM549111patient 047, normal, homogenized [OPG study]8.0908381
GSM549113patient 057, normal, homogenized [OPG study]7.9067780
GSM549132patient 031, cancer, homogenized [OPG study]8.5243485
GSM549137patient 038, cancer, homogenized [OPG study]9.1514190
GSM549142patient 047, cancer, homogenized [OPG study]7.288876
GSM549100patient 110, normal, homogenized [OPG study]7.784580
GSM549107patient 135, normal, homogenized [OPG study]7.7754679
GSM549115patient 068, normal, homogenized [OPG study]7.817279
GSM549116patient 072, normal, homogenized [OPG study]7.9181880
GSM549120patient 078, normal, homogenized [OPG study]7.6472578
GSM549131patient 030, cancer, homogenized [OPG study]9.1370289
GSM549118patient 074, normal, homogenized [OPG study]7.6726578
GSM549129patient 027, cancer, homogenized [OPG study]8.8121388
GSM549123patient 088, normal, homogenized [OPG study]7.2817674
GSM549124patient 006, cancer, homogenized [OPG study]8.2820484
GSM549126patient 015, cancer, homogenized [OPG study]7.3540775
GSM549128patient 025, cancer, homogenized [OPG study]9.1857290
GSM549103patient 117, normal, homogenized [OPG study]6.6632668
GSM549117patient 073, normal, homogenized [OPG study]7.1333773
GSM549138patient 041, cancer, homogenized [OPG study]7.8225879
GSM549141patient 045, cancer, homogenized [OPG study]8.0857281
GSM549130patient 028, cancer, homogenized [OPG study]7.4723277
GSM549101patient 111, normal, homogenized [OPG study]7.5835178
GSM549105patient 128, normal, homogenized [OPG study]7.6865179
GSM549106patient 134, normal, homogenized [OPG study]8.3608183
GSM549112patient 048, normal, homogenized [OPG study]7.8088179
GSM549125patient 011, cancer, homogenized [OPG study]7.5089777
GSM549127patient 024, cancer, homogenized [OPG study]8.5311686
GSM549135patient 035, cancer, homogenized [OPG study]8.7602787